How many employees does Apacscientific have?

As of Jul 31, 2026, the latest employee count at Apacscientific is 3.

Where does Apacscientific rank among its competitors?

Apacscientific ranks 2035th amongst 1970 active competitors, of which 448 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was LifeMine Therapeutics, which secured $75M in Aug, 2026.

Who are the top competitors of Apacscientific?

Apacscientific's top competitors include Antheia, Transcenta and Akeso. Among them, LifeMine Therapeutics secured the most recent funding round in August, 2026.

Apacscientific - 2026 Company Profile & Competitors

Company Details

Provider of scientific equipment maintenance, repair services, and technical training. Operations include the installation of laboratory systems, the calibration of instrumentation, and the delivery of instructional courses for research equipment. Maintenance plans support the operational lifespan of measurement devices and optical sensors. Technical personnel conduct diagnostics and hardware repairs to restore equipment functionality for researchers and laboratory staff.

Website: apacscientific.com
Social

Key Metrics

Stage

Unfunded

Ranked

2035^th among 2680 competitors

Employee Count

3 as on Jul 31, 2026

Similar Companies

Antheia & 2678 more

View Apacscientific's full profile

Apacscientific has not raised any funding rounds yet.

Apacscientific's employee count trend

Apacscientific has 3 employees as of Jul 26. Here is Apacscientific's employee count trend over the years:

Uncover Apacscientific's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Apacscientific include Antheia, Transcenta and Akeso. Here is the list of Top 10 competitors of Apacscientific, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Antheia 2013, Palo Alto (United States), Series C	Genetically engineered yeast cells to produce medicinal products	$176M	Viking Global Investors, ATHOS KG & 15 others	67/100
2nd	Transcenta 2019, Suzhou (China), Public	Developer of antibody-based therapeutics	$205M	Lilly Asia Ventures, Temasek & 11 others	66/100
3rd	Akeso 2012, Zhongshan (China), Public	Developer of antibody drug conjugates for the treatment of broad spectrum diseases	$195M	Loayal Valley Capital, Sino Biopharmaceutical ... & 18 others	65/100
4th	Korro Bio 2018, Cambridge (United States), Public	Provider of RNA editing technologies to develop genetic medicines for rare and prevalent diseases	$4M	Cormorant Asset Management, Atlas Venture ... & 14 others	64/100
5th	Novogene Corporation 2011, Beijing (China), Series B	Provider of genomic services and solutions	$75M	SDIC Innovation, CMB International Capital ... & 4 others	64/100
6th	Fermentalg 2005, Libourne (France), Public	Innovating with algae for sustainable solutions in nutrition and environmental impact	$30.3M	Demeter, Smalt Capital & 14 others	63/100
7th	Microban 1994, Huntersville (United States), Acquired	Antimicrobial and odor control technologies for durable product protection and freshness	$64.6M	TA Associates, UBS & 1 others	63/100
8th	LifeMine Therapeutics 2016, Watertown (United States), Series E	Developer of novel drugs from fungi via genome mining and recombinant overexpression	$563M	Fidelity Investments, 6 Dimensions Capital ... & 17 others	63/100
9th	Dewpoint Therapeutics 2018, Boston (United States), Series D	Developer of small molecule based therapeutics	$364M	Maverick Ventures, SoftBank Vision Fund & 16 others	62/100
10th	One Biosciences 2020, Paris (France), Series A	Developer of single-cell therapeutics solutions to treat multiple health disorders	$22.4M	BLAST Premier, Redmile Group & 6 others	62/100
2035th	Apacscientific Unfunded	Provider of scientific equipment maintenance, repair services, and technical training	-	-	17/100